MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijpharm.2005.09.006

Медицинская библиотека · International journal of pharmaceutics · 2005

Enhancement of brain distribution of anticancer agents using DeltaG, the 12 kDa active fragment of ZOT.

Menon Divya, Karyekar Chetan S, Fasano Alessio, Lu Ruliang, Eddington Natalie D

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

The objective of this study was to evaluate the ability of DeltaG, the 12 kDa active fragment of ZOT, to increase the brain distribution of MTX and paclitaxel, two commonly used anticancer agents with poor distribution into the brain.

METHODS

As part of dose estimation of DeltaG, [14C]-sucrose (40 microCi/kg), a hydrophilic paracellular marker, was co-administered with DeltaG (0, 400 and 800 microg/kg) with and without protease inhibitors to male Sprague-Dawley rats (n=3 per group) via an intracarotid cannula. MTX (50 mg/kg) and [3H]-paclitaxel (120 microCi/kg) were co-administered with the effective doses of DeltaG determined from the above study via the intracarotid cannula. Animals were euthanized by carbon dioxide asphyxiation at the specified time periods and brain and plasma samples were analyzed for the respective drug.

RESULTS

The brain distribution of [14C]-sucrose was significantly enhanced at both doses of DeltaG. A fold enhancement in the B/P ratios of 1.88 and 2.68 was observed at the 400 and 800 microg/kg doses respectively, when the protein was protected from metabolic degradation with PIs. DeltaG significantly increased the brain distribution of MTX at each of the doses administered, with over a seven-fold increase at the 600 microg/kg dose. [3H]-paclitaxel brain AUC(0-60 min) was significantly higher in the presence of DeltaG (800 microg/kg with PIs) with a 2.5-fold enhancement in brain exposure.

CONCLUSIONS

DeltaG significantly enhances the brain distribution of MTX (hydrophilic) and paclitaxel (lipophilic) and has the potential to be further developed as adjunct therapy to increase delivery of poorly permeable chemotherapeutic and other CNS targeted compounds.

Для цитирования: Menon Divya, Karyekar Chetan S, Fasano Alessio, Lu Ruliang, Eddington Natalie D. Enhancement of brain distribution of anticancer agents using DeltaG, the 12 kDa active fragment of ZOT.. International journal of pharmaceutics. 2005. DOI: 10.1016/j.ijpharm.2005.09.006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.